AK Medical repurchases 1.09 million shares for HKD 6.25 million, lifting cumulative buy-backs to 11.19% of mandate base

Bulletin Express

06/03

AK Medical Holdings Limited (AK Medical) reported to the Hong Kong Stock Exchange that it repurchased 1.09 million ordinary shares on 3 June 2026. The on-market transactions were executed at prices ranging from HKD 5.70 to HKD 5.75 per share, resulting in a total consideration of HKD 6.25 million.

Including the latest purchase, AK Medical has bought back 12.56 million shares since the current mandate was approved on 18 June 2025. This volume represents 11.19% of the company’s issued share capital on the mandate’s reference date.

All repurchased shares—1.09 million on 3 June 2026 and 11.47 million from earlier trades—remain pending cancellation. Consequently, the issued share capital is unchanged at 1.12 billion shares as at 3 June 2026.

Under Main Board Rule 10.06(3), AK Medical is restricted from issuing new shares until 3 July 2026, 30 days after the latest buy-back. Ma Rongkun, Company Secretary, confirmed that the transactions complied with all applicable listing rules and regulatory requirements.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1174436460"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1174436460\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1174436460?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-03 21:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1174436460","market":"us","top_or_hot":-1,"title":"AK Medical repurchases 1.09 million shares for HKD 6.25 million, lifting cumulative buy-backs to 11.19% of mandate base","media":"Bulletin Express","content":"<p>AK Medical Holdings Limited (AK Medical) reported to the Hong Kong Stock Exchange that it repurchased 1.09 million ordinary shares on 3 June 2026. The on-market transactions were executed at prices ranging from HKD 5.70 to HKD 5.75 per share, resulting in a total consideration of HKD 6.25 million.</p>\n<p>Including the latest purchase, AK Medical has bought back 12.56 million shares since the current mandate was approved on 18 June 2025. This volume represents 11.19% of the company’s issued share capital on the mandate’s reference date.</p>\n<p>All repurchased shares—1.09 million on 3 June 2026 and 11.47 million from earlier trades—remain pending cancellation. Consequently, the issued share capital is unchanged at 1.12 billion shares as at 3 June 2026.</p>\n<p>Under Main Board Rule 10.06(3), AK Medical is restricted from issuing new shares until 3 July 2026, 30 days after the latest buy-back. Ma Rongkun, Company Secretary, confirmed that the transactions complied with all applicable listing rules and regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AK Medical repurchases 1.09 million shares for HKD 6.25 million, lifting cumulative buy-backs to 11.19% of mandate base</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAK Medical repurchases 1.09 million shares for HKD 6.25 million, lifting cumulative buy-backs to 11.19% of mandate base\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-03 21:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>AK Medical Holdings Limited (AK Medical) reported to the Hong Kong Stock Exchange that it repurchased 1.09 million ordinary shares on 3 June 2026. The on-market transactions were executed at prices ranging from HKD 5.70 to HKD 5.75 per share, resulting in a total consideration of HKD 6.25 million.</p>\n<p>Including the latest purchase, AK Medical has bought back 12.56 million shares since the current mandate was approved on 18 June 2025. This volume represents 11.19% of the company’s issued share capital on the mandate’s reference date.</p>\n<p>All repurchased shares—1.09 million on 3 June 2026 and 11.47 million from earlier trades—remain pending cancellation. Consequently, the issued share capital is unchanged at 1.12 billion shares as at 3 June 2026.</p>\n<p>Under Main Board Rule 10.06(3), AK Medical is restricted from issuing new shares until 3 July 2026, 30 days after the latest buy-back. Ma Rongkun, Company Secretary, confirmed that the transactions complied with all applicable listing rules and regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01789","symbol_name":"爱康医疗","start_time":0,"source_url":"","article_id":"1174436460","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1174436460","pubTimestamp":1780491912,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"AK Medical Holdings Limited (AK Medical) reported to the Hong Kong Stock Exchange that it repurchased 1.09 million ordinary shares on 3 June 2026. The on-market transactions were executed at prices...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01789":"爱康医疗"},"translate_title":"爱康医疗625万港元回购109万股累计回购升至授权基数11.19%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01789":1},"content_text":"AK Medical Holdings Limited (AK Medical) reported to the Hong Kong Stock Exchange that it repurchased 1.09 million ordinary shares on 3 June 2026. The on-market transactions were executed at prices ranging from HKD 5.70 to HKD 5.75 per share, resulting in a total consideration of HKD 6.25 million.\nIncluding the latest purchase, AK Medical has bought back 12.56 million shares since the current mandate was approved on 18 June 2025. This volume represents 11.19% of the company’s issued share capital on the mandate’s reference date.\nAll repurchased shares—1.09 million on 3 June 2026 and 11.47 million from earlier trades—remain pending cancellation. Consequently, the issued share capital is unchanged at 1.12 billion shares as at 3 June 2026.\nUnder Main Board Rule 10.06(3), AK Medical is restricted from issuing new shares until 3 July 2026, 30 days after the latest buy-back. Ma Rongkun, Company Secretary, confirmed that the transactions complied with all applicable listing rules and regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}